N-Ethyl-4-hydroxy-N-methyl-2-oxo-1H-1,7-naphthyridine-3-carboxamide

ID: ALA4578848

PubChem CID: 155565224

Max Phase: Preclinical

Molecular Formula: C12H13N3O3

Molecular Weight: 247.25

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(C)C(=O)c1c(O)c2ccncc2[nH]c1=O

Standard InChI:  InChI=1S/C12H13N3O3/c1-3-15(2)12(18)9-10(16)7-4-5-13-6-8(7)14-11(9)17/h4-6H,3H2,1-2H3,(H2,14,16,17)

Standard InChI Key:  UNDSRBFKGILIBW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   25.5172   -3.2563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5161   -4.0759    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.2241   -4.4848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2223   -2.8475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9310   -3.2527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9344   -4.0779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6467   -4.4853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.3603   -4.0721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3569   -3.2469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6400   -2.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0691   -4.4788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6355   -2.0178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0633   -2.8361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7723   -3.2425    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0608   -2.0189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.4788   -2.8317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1877   -3.2381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7748   -4.0597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  8 11  2  0
 10 12  1  0
  9 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 14 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4578848

    ---

Associated Targets(Human)

KDM5A Tchem Lysine-specific demethylase 5A (893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 247.25Molecular Weight (Monoisotopic): 247.0957AlogP: 0.72#Rotatable Bonds: 2
Polar Surface Area: 86.29Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.18CX Basic pKa: 3.50CX LogP: -0.94CX LogD: -2.94
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.82Np Likeness Score: -0.74

References

1. Labadie SS, Dragovich PS, Cummings RT, Deshmukh G, Gustafson A, Han N, Harmange JC, Kiefer JR, Li Y, Liang J, Liederer BM, Liu Y, Manieri W, Mao W, Murray L, Ortwine DF, Trojer P, VanderPorten E, Vinogradova M, Wen L..  (2016)  Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.,  26  (18): [PMID:27499454] [10.1016/j.bmcl.2016.07.070]

Source